BioLargo (NASDAQ:BLGO – Get Free Report) and Ingevity (NYSE:NGVT – Get Free Report) are both small-cap construction companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.
Profitability
This table compares BioLargo and Ingevity’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| BioLargo | -16.53% | -58.35% | -32.12% |
| Ingevity | -27.85% | 19.59% | 4.22% |
Analyst Recommendations
This is a breakdown of recent ratings and target prices for BioLargo and Ingevity, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| BioLargo | 0 | 0 | 0 | 0 | N/A |
| Ingevity | 0 | 3 | 3 | 0 | 2.50 |
Risk & Volatility
BioLargo has a beta of 0.18, indicating that its share price is 82% less volatile than the S&P 500. Comparatively, Ingevity has a beta of 1.62, indicating that its share price is 62% more volatile than the S&P 500.
Institutional and Insider Ownership
0.0% of BioLargo shares are held by institutional investors. Comparatively, 91.6% of Ingevity shares are held by institutional investors. 20.3% of BioLargo shares are held by insiders. Comparatively, 1.1% of Ingevity shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Earnings & Valuation
This table compares BioLargo and Ingevity”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| BioLargo | $12.23 million | 5.81 | -$3.50 million | ($0.03) | -7.97 |
| Ingevity | $1.55 billion | 0.83 | -$112.98 million | ($3.11) | -11.38 |
BioLargo has higher earnings, but lower revenue than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than BioLargo, indicating that it is currently the more affordable of the two stocks.
Summary
Ingevity beats BioLargo on 7 of the 13 factors compared between the two stocks.
About BioLargo
BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per – and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.
About Ingevity
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, paper chemicals, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts and components manufacturers through sales representatives and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
Receive News & Ratings for BioLargo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLargo and related companies with MarketBeat.com's FREE daily email newsletter.
